Skip to Main Content

Scores of promising technologies that have been spun out of a university wind up gathering dust, once they’ve been licensed by a pharmaceutical company.

That’s because tech transfer offices often license out technology when it’s still very early stage — and drug makers at times give up trying to validate them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!